留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x

超声应变成像获得的左房机械离散度可作为新发房颤的预测指标

黄志勇 胡孜阳 吴杰莹 罗伟权 刘娟娟

黄志勇, 胡孜阳, 吴杰莹, 罗伟权, 刘娟娟. 超声应变成像获得的左房机械离散度可作为新发房颤的预测指标[J]. 分子影像学杂志, 2022, 45(4): 511-517. doi: 10.12122/j.issn.1674-4500.2022.04.09
引用本文: 黄志勇, 胡孜阳, 吴杰莹, 罗伟权, 刘娟娟. 超声应变成像获得的左房机械离散度可作为新发房颤的预测指标[J]. 分子影像学杂志, 2022, 45(4): 511-517. doi: 10.12122/j.issn.1674-4500.2022.04.09
HUANG Zhiyong, HU Ziyang, WU Jieying, LUO Weiquan, LIU Juanjuan. Predictive value of left atrial mechanical dispersion measured by ultrasound strain imaging for new-onset atrial fibrillation[J]. Journal of Molecular Imaging, 2022, 45(4): 511-517. doi: 10.12122/j.issn.1674-4500.2022.04.09
Citation: HUANG Zhiyong, HU Ziyang, WU Jieying, LUO Weiquan, LIU Juanjuan. Predictive value of left atrial mechanical dispersion measured by ultrasound strain imaging for new-onset atrial fibrillation[J]. Journal of Molecular Imaging, 2022, 45(4): 511-517. doi: 10.12122/j.issn.1674-4500.2022.04.09

超声应变成像获得的左房机械离散度可作为新发房颤的预测指标

doi: 10.12122/j.issn.1674-4500.2022.04.09
基金项目: 

中山市医学科研项目 2021J133

详细信息
    作者简介:

    黄志勇,硕士,副主任医师,E-mail: 407371975@qq.com

Predictive value of left atrial mechanical dispersion measured by ultrasound strain imaging for new-onset atrial fibrillation

  • 摘要:   目的   应用超声应变成像定量评估左房机械离散度与新发房颤的关系,探讨其预测房颤在左房扩大及左房功能障碍之外的增量价值。   方法   选取2018~2021年有房颤风险的376例一般人群作为受试者行心电图检查,随访3年后选取有新发房颤的35例受试者作为研究组,在同一队列中选取与研究组相等例数且年龄性别相匹配的未出现房颤受试者作为对照组。应用超声应变成像测量两组的12节段左房应变值,获取并分析两组的左房容积指数(LAVI)、左房泵应变(LAPS)、左房储器应变(LARS)及左房机械离散度(SD-TPS)的差异性。SD-TPS定义为经R-R间期标化的左房各节段储器应变达峰时间标准差。校正患者基线资料、LAVI、LAPS、LARS,分析SD-TPS与新发房颤的独立相关性及其增量预测价值。   结果   两组LAVI的差异无统计学意义(32.5±9.2 mL/m2 vs 29.5±8.3 mL/m2P=0.16);研究组的LAPS[(16.6±4.3)% vs (20.6±4.3)%,P < 0.01]和LARS[(31.4±7.7)% vs(38.0±7.3)%,P < 0.01]低于对照组;研究组的SD-TPS高于对照组([6.3±2.3)% vs (3.9±1.6)%,P < 0.01]。调整了CHARGE-AF评分、LAVI和LARS后,SD-TPS仍与新发房颤独立相关(危险比1.26,95%CI=1.10-1.45,P < 0.01)。Cox比例风险回归模型中,SDTPS预测新发房颤可提供左房容积及左房应变之外的增量价值(P < 0.01)。   结论   从超声应变成像中获得的左房机械离散度可作为新发房颤风险分层的有效预测指标,在预测新发房颤方面可提供左房容积及左房功能障碍之外的增量价值。

     

  • 图  1  左房应变参数的测量

    A:左房各节段应变曲线及应变达峰时间;B:左房应变分量示意图.

    Figure  1.  Measurement of left atrial strain parameters.

    图  2  两组代表性案例的左房应变曲线和SD-TPS

    A:房颤患者,SD-TPS=6.3%;B:非房颤患者,SD-TPS=2.3%.

    Figure  2.  Measurements of left atrium dispersion and representative cases in patients with and without AF

    图  3  新发房颤的生存曲线分析(SD-TPS=5.3%)

    Figure  3.  Kaplan-Meier curves showing freedom from new-onset atrial fibrillation (SD-TPS=5.3%).

    表  1  患者基线特征

    Table  1.   Patient baseline characteristics

    项目 所有患者(n=70) 研究组(n=35) 对照组(n=35) P
    年龄(岁,Mean±SD) 70±4 70±4 70±4 -
    性別[男,n(%)] 40(57) 20(57) 20(57) -
    体表面积(m2Mean±SD) 1.9±0.2 2.0±0.2 1.9±0.2 0.82
    BMI (kg/m2, Mean±SD) 29.5±4.6 29.7±5.0 29.4±4.3 0.79
    肥胖[n(%)] 3(44) 14(40) 17(49) 0.47
    2型糖尿病[n(%)] 34(49) 18(51) 16(46) 0.73
    高脂血症[n(%)] 32(48) 15(45) 17(49) 0.71
    高血压[n(%)] 53(76) 27(77) 26(74) 0.78
    CHA2DS2-VASc评分(Mean±SD) 3.0±1.0 3.1±0.9 3.0±1.0 0.71
    CHARGE-AF评分 8.3(5.0, 12.7) 6.9(5.1, 12.2) 8.7(4.8, 14) 0.49
    用药情况[n(%)]
      ACEI或ARBs 44(63) 20(57) 24(69) 0.32
      b受体阻滞剂 7(10) 5(14) 2(6) 0.43
      钙桔抗剂 16(23) 5(14) 11(37) 0.06
      降血脂药 33(47) 15(43) 18(51) 0.30
      抗血小板药 19(27) 9(26) 10(29) 0.66
    超声心动图参数(Mean±SD)
      LVEF(%) 62.7±6.2 61.3±6.3 64.1±5.8 0.06
      GLS(%) -18.5±2.7 -18.1±3.3 -18.8±1.9 0.46
      GCS(%) -29.9±5.4 -29.9±5.8 -30.0±5.0 0.94
      E/e' 8.9±2.7 8.6±2.6 9.1±2.8 0.44
      LAVl(mL/m2) 31.0±8.8 32.5±9.2 29.5±8.3 0.16
      LAPS(%) 18.6±4.7 16.6±4.3 20.6±4.3 < 0.01
      LACS(%) 16.0±5.2 14.8±4.9 17.1±5.4 0.06
      LARS(%) 34.7±8.1 31.4±7.7 38.0±7.3 < 0.01
      SD-TPSC%) 5.1±2.3 6.3±2.3 3.9±1.6 < 0.01
    LVEF:左室射血分数;GLS:整体纵向应变;GCS:整体圆周应变;E/e’:舒张早期二尖瓣口血流速度/舒张早期二尖瓣瓣环运动速度;LAVI:左房容积指数;LAPS:左房泵应变;LACS:左房管道应变;LARS:左房储器应变;SD-TPS:左房机械离散度(经R-R间期标化的左房各节段储器应变达峰时间标准差)
    下载: 导出CSV

    表  2  SD-TPS与其他超声心动图参数的线性回归分析

    Table  2.   Associations of SD-TPS and other echocardiographic parameters

    参数 单变量线性回归分析 多变量线性回归分析
    非标准系数b 标准系数b P 非标准系数b 标准系数b P
    LVEF -0.144(-0.227, -0.060) -0.384 < 0.01 -0.101(-0.190, -0.013) -0.271 0.03
    GCS 0.036(-0.068, 0.140) 0.083 0.49
    GLS 0.292(0.098, 0.486) 0.342 < 0.01 0.118(-0.095, 0.330) 0.138 0.27
    E/e' 0.187(-0.015, 0.388) 0.219 0.07
    LAVI 0.051(-0.011, 0.114) 0.196 0.10 0.012(-0.050, 0.075) 0.047 0.69
    LAPS 0.123(-0.238, -0.007) -0.249 0.04
    LARS 0.109(-0.173, -0.046) -0.385 < 0.01 -0.076(-0.147,-0.004) -0.266 0.04
    下载: 导出CSV

    表  3  SD-TPS与其他超声心动图参数的相关性

    Table  3.   Correlation between SD-TPS and other echocardiographic parameters

    参数 r P
    LVEF -0.384 < 0.01
    GCS 0.083 0.49
    GLS 0.342 < 0.01
    E/e' 0.219 0.07
    LAVI 0.196 0.10
    LAPS -0.249 0.04
    LARS -0.385 < 0.01
    下载: 导出CSV

    表  4  新发房颤相关因素的Cox比例风险回归模型分析

    Table  4.   Univariable and multivariable Cox regression analysis for new-onset atrial fibrillation

    因素 单因素 多因素
    临床资料模型 药物治疗模型 超声检测模型
    HR (95% CI) P HR (95% CI) P HR (95% CI) P HR (95% CI) P
    BMI 1.00 (0.94~1.07) 0.94 0.96 (0.89~1.04) 0.30
    CHA2DS2-VASc评分 1.05 (0.76~1.45) 0.79 0.97 (0.65~1.44) 0.87
    CHARGE-AF评分 0.97 (0.90~1.04) 0.41 0.96 (0.88~1.05) 0.35
    ACEI或ARBs 1.58(0.81~3.10) 0.18 1.89 (0.85~4.21) 0.12
    b受体阻滞剂 0.57 (0.22~1.50) 0.26 0.52 (0.16~1.66) 0.27
    钙桔抗剂 1.58(0.61~4.09) 0.35 1.80 (0.67~4.86) 0.25
    LVEF 0.96 (0.91~1.01) 0.08 1.02 (0.96~1.08) 0.59
    LAVI 1.04(1.00~1.07) 0.04 1.00 (0.95~1.08) 0.88
    LARS 0.92 (0.88~0.96) < 0.01 0.93 (0.86~0.99) 0.02
    SD-TPS 1.32(1.17~1.50) < 0.01 1.37 (1.20~1.59) < 0.01 1.37(1.21~1.56) < 0.01 1.28 (1.08~1.51) < 0.01
    下载: 导出CSV

    表  5  LARS与SD-TPS预测新发房颤的增量价值

    Table  5.   Incremental value of LARS and SD-TPS in predicting new-onset atrial fibrillation

    项目 模型1(χ2=5.3) 模型2(χ2=17.8) 模型3(χ2=27.5)
    HR (95%CI) P HR (95%CI) P HR (95%CI) P
    CHARGE-AF评分 0.96 (0.90~1.04) 0.33 0.93 (0.86~1.01) 0.07 0.93 (0.85~1.00) 0.06
    LAVI 1.04 (1.00~1.07) 0.03 1.00 (0.96~1.04) 0.81 1.00 (0.96~1.05) 0.99
    LARS 0.90 (0.85~0.95) < 0.01 0.92 (0.86~0.98) < 0.01
    SD-TPS 1.26(1.10~1.45) < 0.01
    下载: 导出CSV

    表  6  超声心动图参数的ROC曲线分析

    Table  6.   ROC curve analysis of echocardiographic variables

    参数 AUC 95%CI P 截点值(%) 敏感性(%) 特异性(%) 阳性预测值(%) 阴性预测值(%)
    SD-TPSC%) 0.80 0.69~0.90 < 0.01 5.3 65.7 85.7 82.1 71.4
    LARS(%) 0.75 0.63~0.87 < 0.01 36.8 82.9 65.7 70.7 79.3
    LVEF(%) 0.62 0.49~0.76 0.08 63.6 71.4 54.3 61.0 65.5
    LAVl(mL/m2) 0.59 0.46~0.73 0.18 28.9 62.9 51.4 56.4 58.1
    GLS(%) 0.55 0.41~0.69 0.46 17.6 45.7 71.4 61.5 56.8
    下载: 导出CSV
  • [1] Hoit BD. Left atrial size and function: role in prognosis[J]. J Am Coll Cardiol, 2014, 63(6): 493-505. doi: 10.1016/j.jacc.2013.10.055
    [2] Fatema K, Barnes ME, Bailey KR, et al. Minimum vs. maximum left atrial volume for prediction of first atrial fibrillation or flutter in an elderly cohort: a prospective study[J]. Eur J Echocardiogr, 2009, 10(2): 282-6.
    [3] Conen D, Glynn RJ, Sandhu RK, et al. Risk factors for incident atrial fibrillation with and without left atrial enlargement in women [J]. Int J Cardiol, 2013, 168(3): 1894-9. doi: 10.1016/j.ijcard.2012.12.060
    [4] Hirose T, Kawasaki M, Tanaka R, et al. Left atrial function assessed by speckle tracking echocardiography as a predictor of new-onset non-valvular atrial fibrillation: results from a prospective study in 580 adults[J]. Eur Heart J Cardiovasc Imaging, 2012, 13(3): 243-50. doi: 10.1093/ejechocard/jer251
    [5] Haugaa KH, Goebel B, Dahlslett T, et al. Risk assessment of ventricular arrhythmias in patients with nonischemic dilated cardiomyopathy by strain echocardiography[J]. J Am Soc Echocardiogr, 2012, 25(6): 667-73. doi: 10.1016/j.echo.2012.02.004
    [6] Ciuffo L, Tao S, Gucuk Ipek E, et al. Intra-atrial dyssynchrony during sinus rhythm predicts recurrence after the first catheter ablation for atrial fibrillation[J]. JACC Cardiovasc Imaging, 2019, 12(2): 310-9. doi: 10.1016/j.jcmg.2017.11.028
    [7] 沙雨佳. 左心房应变及机械离散度预测房颤患者射频消融术后复发的研究[D]. 大连: 大连医科大学, 2021.
    [8] Kim IS, Kim TH, Shim CY, et al. The ratio of early transmitral flow velocity (E) to early mitral annular velocity (Em) predicts improvement in left ventricular systolic and diastolic function 1 year after catheter ablation for atrial fibrillation[J]. Europace, 2015, 17(7): 1051-8. doi: 10.1093/europace/euu346
    [9] Hong J, Gu XY, An P, et al. Left atrial functional remodeling in lone atrial fibrillation: a two-dimensional speckle tracking echocardiographic study[J]. Echocardiography, 2013, 30(9): 1051-60.
    [10] Saraiva RM, Demirkol S, Buakhamsri A, et al. Left atrial strain measured by two-dimensional speckle tracking represents a new tool to evaluate left atrial function[J]. J Am Soc Echocardiogr, 2010, 23(2): 172-80. doi: 10.1016/j.echo.2009.11.003
    [11] Cameli M, Lisi M, Righini FM, et al. Novel echocardiographic techniques to assess left atrial size, anatomy and function[J]. Cardiovasc Ultrasound, 2012, 10: 4. doi: 10.1186/1476-7120-10-4
    [12] Shang ZJ, Su DC, Cong T, et al. Assessment of left atrial mechanical function and synchrony in paroxysmal atrial fibrillation with two-dimensional speckle tracking echocardiography[J]. Echocardiography, 2017, 34(2): 176-83. doi: 10.1111/echo.13434
    [13] Mochizuki A, Yuda S, Oi Y, et al. Assessment of left atrial deformation and synchrony by three-dimensional speckle-tracking echocardiography: comparative studies in healthy subjects and patients with atrial fibrillation[J]. J Am Soc Echocardiogr, 2013, 26 (2): 165-74. doi: 10.1016/j.echo.2012.10.003
    [14] Watanabe Y, Nakano Y, Hidaka T, et al. Mechanical and substrate abnormalities of the left atrium assessed by 3-dimensional speckletracking echocardiography and electroanatomic mapping system in patients with paroxysmal atrial fibrillation[J]. Heart Rhythm, 2015, 12(3): 490-7. doi: 10.1016/j.hrthm.2014.12.007
    [15] Sarvari SI, Haugaa KH, Stokke TM, et al. Strain echocardiographic assessment of left atrial function predicts recurrence of atrial fibrillation[J]. Eur Heart J Cardiovasc Imaging, 2016, 17(6): 660-7. doi: 10.1093/ehjci/jev185
    [16] Hongning Y, Ruiqin X, Jing W, et al. Assessment of left atrial function and dyssynchrony by real time three-dimensional echocardiography predicts recurrence of paroxysmal atrial fibrillation after radiofrequency ablation[J]. Eur Rev Med Pharmacol Sci, 2018, 22(10): 3151-9.
    [17] Kupczynska K, Michalski BW, Miskowiec D, et al. Incremental value of left atrial mechanical dispersion over CHA 2 DS 2-VASc score in predicting risk of Thrombus formation[J]. Echocardiography, 2018, 35(5): 651-60. doi: 10.1111/echo.13899
    [18] Bonapace S, Valbusa F, Bertolini L, et al. Early impairment in left ventricular longitudinal systolic function is associated with an increased risk of incident atrial fibrillation in patients with type 2 diabetes[J]. J Diabetes Complications, 2017, 31(2): 413-8. doi: 10.1016/j.jdiacomp.2016.10.032
    [19] Magnani JW, Zhu L, Lopez F, et al. P-wave indices and atrial fibrillation: cross-cohort assessments from the Framingham Heart Study (FHS) and Atherosclerosis Risk in Communities (ARIC) study[J]. Am Heart J, 2015, 169(1): 53-6111. doi: 10.1016/j.ahj.2014.10.009
    [20] Schumacher K, Dagres N, Hindricks G, et al. Characteristics of PR interval as predictor for atrial fibrillation: association with biomarkers and outcomes[J]. Clin Res Cardiol, 2017, 106(10): 767-75. doi: 10.1007/s00392-017-1109-y
  • 加载中
图(3) / 表(6)
计量
  • 文章访问数:  193
  • HTML全文浏览量:  120
  • PDF下载量:  10
  • 被引次数: 0
出版历程
  • 收稿日期:  2022-02-27
  • 网络出版日期:  2022-07-25
  • 刊出日期:  2022-07-20

目录

    /

    返回文章
    返回

    关于《分子影像学杂志》变更刊期通知

    各位专家、作者、读者:

    为了缩短出版时滞,促进科研成果的快速传播,我刊自2024年1月起,刊期由双月刊变更为月刊。本刊主要栏目有:基础研究、临床研究、技术方法、综述等。

    感谢各位专家、作者、读者长期以来对我刊的支持与厚爱!

    南方医科大学学报编辑部

    《分子影像学杂志》

    2023年12月27日